NCT00957788View on ClinicalTrials.gov

Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Tinnitus
Interventions
DRUG

NST-001

Comparison of different dosages of drug.

Trial Locations (2)

93009

Hôpital Avicenne, Bobigny

Unknown

Cliniques Universitaries U.C.L., Mont-Godinne

Sponsors
All Listed Sponsors
lead

NeuroSystec Corporation

INDUSTRY